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Abstract. Peripheral artery disease (PAD) is a common condition with high morbidity. While measurement of tissue
oxygen saturation (StO2) has been demonstrated, this is the first study to assess both StO2 and relative blood flow
(rBF) in the extremities of PAD patients. Diffuse optics is employed to measure hemodynamic response to treadmill
and pedal exercises in 31 healthy controls and 26 patients. For StO2, mild and moderate/severe PAD groups show
pronounced differences compared with controls. Pre-exercise mean StO2 is lower in PAD groups by 9.3% to 10.6%
compared with means of 63.5% to 66.2% in controls. For pedal, relative rate of return of StO2 to baseline is more
rapid in controls (p < 0.05). Patterns of rBF also differ among groups. After both exercises, rBF tend to occur
at depressed levels among severe PAD patients compared with healthy (p < 0.05); post-treadmill, rBF tend to
occur at elevated levels among healthy compared with severe PAD patients (p < 0.05). Additionally, relative
rate of return to baseline StO2 is more rapid among subjects with reduced levels of depression in rBF
(p ¼ 0.041), even after adjustment for ankle brachial index. This suggests a physiologic connection between
rBF and oxygenation that can be measured using diffuse optics, and potentially employed as an evaluative
tool in further studies. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.5.057007]
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1 Introduction
Peripheral artery disease (PAD) affects approximately 10 mil-
lion people in the United States.1 The disease is characterized
by progressive narrowing of arteries in the extremities, leading
to reduction in tissue blood supply and tissue ischemia.2,3 In the
most severe cases, critical limb ischemia may manifest as rest
pain or limb ulceration.
The traditional method to diagnose PAD is the ankle brachial
index (ABI), which is simply the ratio of ankle and brachial
systolic blood pressures. Generally, a resting ABI < 0.90 is
believed to be caused by arterial stenosis and defines patients
as having PAD.4 However, while ABI has good sensitivity
for identification of patients with PAD, it does not correlate
well with degree of exercise impairment5 and is technically lim-
ited when supernormal pressures are encountered in patients
with medial artery calcification.6 Further, while the ABI method
is useful for determination of responses to revascularization,
patients with a stent or bypass generally show an increase in
ABI independent of claudication symptoms.7 Also, ABI is
not an accurate predictor of mild disease.8 Thus development
of noninvasive methods for routine and direct measurement
of tissue oxygenation and blood flow in the extremities could
significantly improve initial and follow-up evaluation of PAD
patients.
Diffuse optical techniques provide direct, noninvasive,
assessment of oxygenation and perfusion processes at the micro-
vasculature level.9–11 These techniques have several attractive
features including portability, high temporal resolution, and
the ability to probe deep tissues noninvasively. Diffuse optics
employs near-infrared photons that diffuse through tissue and
can be detected centimeters from the source. In diffuse optical
spectroscopy, also known as near-infrared spectroscopy (NIRS),
the absorption interactions of light with tissue chromophores,
i.e., oxy- (HbO2) and deoxy-hemoglobin (Hb), provide dynamic
information about their concentrations and tissue oxygen satu-
ration (StO2).
9 Diffuse correlation spectroscopy (DCS) mea-
sures temporal fluctuations in the reflected light intensity.
These temporal fluctuations are primarily caused by photons
that have been scattered by moving scatterers such as red
blood cells. Specifically, the temporal intensity autocorrelation
function of detected light is measured, and correlation diffusion
theory is employed to fit the measured curve using a tissue blood
flow index (BFI) as a fitting parameter.10 The BFI is not a meas-
urement of absolute blood flow. However, the DCS technique
has been used to derive relative variation of microvascular
blood flow, relative blood flow (rBF), with respect to baseline
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in a variety of preclinical studies,12–15 and in clinical studies
of cerebrovascular diseases,16–19 muscle physiology,20–23 and
cancer.24 Further, during some of the studies cited above,
DCS was successfully compared with more traditional clinical
perfusion measurements such as arterial spin-labeled magnetic
resonance imaging,12,21 fluorescent microspheres,14 Xenon-
computed tomography,18 and transcranial Doppler ultrasound.19
In the present investigation, the two diffuse optical methods
(NIRS and DCS) were employed in a single instrument in order
to ascertain and compare muscle exercise blood flow and oxy-
genation responses in healthy subjects versus patients with two
severities of PAD (as determined by ABI). Simultaneous optical
measurement of tissue blood flow and tissue oxygenation ena-
bles more comprehensive investigation of exercise physiology
in patients with PAD and, ultimately, may offer a useful new
device for translation to the clinical vascular laboratory.
2 Methods
2.1 Subjects and Protocol
Sixty adult subjects were recruited, either from the vascular
laboratory in the cardiovascular clinic (patients) or using
local advertisements (healthy controls). For this clinical trial, 57
subjects contributed data. One subject refused the study post-
enrollment, one had corrupted optical data, and one was missing
all demographic data.
We report results of two tasks requested of each subject:
plantar flexion (pedal) and treadmill exercise. Both tasks
were performed on the same day and in the same order, for
each subject. For pedal, the first exercise, subjects were in
the supine position during the test protocol. The resistance of
the exercise device remained constant, and the maximal force
of each individual was tested prior to the task. Subjects were
then instructed to perform up to 30 plantar flexion exercises
within 2 min, at 50% of their maximal force. The treadmill
exercise was carried out after a short rest, following the comple-
tion of the plantar flexion, according to the Gardner
protocol.25,26 Subjects walked on the treadmill at a constant
speed (2 miles∕h) for up to 10 min. The platform inclination
was raised 2 deg every 2 min. All procedures were approved
by the Institutional Review Board at the University of
Pennsylvania, where the experiments were carried out. Informed
consent was obtained from all subjects prior to enrollment into
the study.
The optical probe was placed over the calf flexor to make
NIRS and DCS measurements. StO2 and relative blood flow
change from baseline (rBF) were calculated from these measure-
ments as described in the sections below. StO2 was obtained
before, during, and after exercise, but rBF was obtained only
before and after exercise because DCS measurements were
susceptible to motion artifacts caused by muscle motion during
exercise.23,27 In order to investigate potential differences
across different levels of PAD, subjects were separated into
three groups according to their ABI: healthy population
(ABI > 0.9; n ¼ 31); mild PAD patients (0.9 > ABI > 0.7;
n ¼ 11), and moderate/severe PAD patients (0.7 > ABI > 0.3;
n ¼ 15).
2.2 Optical Measurements
A hybrid diffuse optical device was built and employed to assess
blood flow and oxygenation in muscle.20 The DCS module
uses a continuous-wave, long-coherence length 785-nm laser
(CrystaLaser Inc., Reno, Nevada). Four photon-counting ava-
lanche photodiodes (PerkinElmer, Canada) feed a four-channel
autocorrelator board (Correlator.com, Bridgewater, New Jersey)
that computes the temporal intensity autocorrelation function
(g2) of collected light. The NIRS module employs three laser
diodes in the near-infrared (685, 785, and 830 nm; Thorlabs,
Newton, New Jersey). The laser diodes are amplitude modulated
at 70 MHz. Light collected from the tissue was delivered to four
photomultiplier tubes (PMTs; Hamamatsu Corp., Japan), and
the PMT signals were bandpass filtered, amplified, demodu-
lated, and digitized. A laptop computer controlled both DCS
and NIRS modules and recorded data. Two optical switches
(Dicon Fiberoptics, Richmond, California) were employed to
select among the four lasers (three from NIRS and one from
DCS) and the three different source positions on the muscle.
Optical data were acquired from 2 min prior to the start of
the task (baseline period) until 4 min after the task was finished
(recovery period). The whole data acquisition cycle of NIRS and
DCS took approximately 2.5 s.
The optical probe was placed over the calf flexor in a region
that covered approximately an area equivalent to a circle of
3.5 cm radius, similar to previous studies involving muscle
(Fig. 1).20,21 The source-detector distance ranged from 0.5 to
3.8 cm, so that the depth probed was approximately 1.5 to
2.0 cm into the muscle. Black, rigid, plastic material was
used to tightly hold the fibers in place, and elastic straps
fixed the probe around the muscle to reduce motion artifacts
during exercise.
2.3 Optical Data Analysis
For NIRS, the arrangement of optodes permitted continuous
measurement of absolute absorption coefficients by calibrating
the source and detector coupling coefficients with a self-calibrat-
ing approach.20 Absolute HbO2 and Hb concentrations were
then derived from the absorption coefficients.9 Total hemo-
globin concentration (THC) and StO2 were estimated as
THC ¼ HbO2 þ Hb and StO2¼ HbO2∕THC.
For DCS, rBF changes were estimated from DCS data by
extracting a BFI for each source-detector separation at each
time point. (rBFðtÞ ¼ BFIðtÞ∕BFIðt0Þ, where t0 denotes the
baseline period.) The BFI was estimated by fitting the measured
intensity autocorrelation function to the solution of the photon
correlation diffusion equation in the semi-infinite geometry with
extrapolated zero boundary conditions.9,10 In this work, the dif-
fusive motion model was used to approximate the mean-square
particle displacement of the moving red blood cells in tissue and
Laser Source
Flow Detector
Oxygenation 
Detector
3.5 cm
Fig. 1 Schematics of the optical probe designed for the study, contain-
ing three laser sources, four detectors for tissue oxygen saturation
(StO2), and four detectors for relative blood flow (rBF). The probe covers
an area of approximately 40 cm2 on the calf flexor. The different
source-detector distances range from 0.5 to 3.8 cm, and are combined
to provide a single measure of StO2 and an average measure of rBF.
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thus derive the BFI. The changes in the absorption coefficient at
785 nm measured by NIRS were used as input in the correlation
diffusion equation. The goodness of fit was evaluated for each
source-detector separation at each time point, and the decay
curves that failed to fit the model (i.e., curves whose fitting
residuals were higher than 75% of the mean residual over the
entire time-series) were discarded from the analysis. For sta-
tistical analysis, changes in rBF were derived from changes
just after exercise relative to the period prior to exercise and
averaged over all source-detector separations. Figure 2 shows
representative time courses of rBF and StO2 for two different
subjects (one healthy control and one moderate/severe PAD
patient) during both tasks. Although StO2 was also obtained
during exercise, in order to maintain correspondence with
DCS data, we only analyzed changes in the StO2 data before
and after exercise.
2.4 Statistical Analysis
The baseline covariate data for each ABI group were summa-
rized using the median and interquartile range (IQR) for con-
tinuous variables or counts (proportions) for categorical data.
Kruskal-Wallis tests were used to assess differences in exercise
times and the amount of power or work, defined as the product
of the power and the length of exercise. Spearman’s correlation
coefficient, ρ, was used to measure the association between
exercise times.
To explore differences between healthy and PAD patients,
mixed effects models were used as the basic tool to describe
both pre-exercise means as well as post-exercise temporal pat-
terns in rBF and StO2 (Ref. 28). The models for StO2 incorpo-
rated baseline mean StO2 levels for each individual as a
covariate and allowed nonlinear changes over time; the models
for rBF allowed either a constant rate or linear changes over time
(see Appendix for details on model selection). While the model
fits a continuous curve, we illustrate our results with means and
95% confidence intervals (95% CI) at specific time points
(immediately post-exercise, 0.5, 1, and 3 min). We note that
while data were potentially collected up until about 4 min
post exercise, there was substantial missing data for some sub-
jects toward the end of the collection period. Thus we chose
to illustrate results for the first 3 min as the dataset is much
more complete across subjects for this time period. Overall
significance of the model was determined using a likelihood
ratio test; contrasts between specific terms were based on Wald
tests. p-Values for pair-wise comparisons among ABI groups
were adjusted using a Bonferroni correction.
The mixed effects models explored differences among ABI
groups in temporal patterns of StO2 and rBF, assuming that all
individuals within an ABI group follow the same mean pattern
over time. To relax this assumption, we analyzed the StO2 data
using time to return to baseline as the outcome of interest.
Because several individuals did not return to baseline by the
end of our monitoring period, we estimated the median time
to return to baseline levels using Kaplan-Meir methods, and
then used a Cox model to test the hypothesis that differences
in the relative risk, or equivalently, rate of returning to baseline
are associated with ABI group or actual ABI value.
TREADMILL PEDAL
Exercise
Exercise Exercise
Exercise
Fig. 2 Representative time-courses of StO2 (top row) and rBF (bottom row) for a moderate/severe peripheral artery disease (PAD) patient and a healthy
control for the treadmill (left column) and pedal (right column) exercises. The gray area indicates the duration of the exercise, while the up (down) arrow
indicates the start (end) of the exercise. Note, StO2 was obtained before, during and after exercise, but rBF was accurately obtained only before and after
exercise (due to motion artifacts that arise during exercise). The statistical analysis was performed for the period after cessation of the exercise, taking the
period immediately before each exercise as the baseline.
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In contrast with StO2, individual traces for rBF often did not
return to baseline over the measured post-exercise period, and,
for some individuals, outlier values were not uncommon. Here,
for each exercise, we used a Kruskal-Wallis test to determine
whether there were differences in the extremes of the distribu-
tion of rBF among ABI groups. Specifically we examined the
median proportion of post-exercise interval that the rBF mea-
surements for an individual were either elevated (>1.5 fold
baseline) or depressed (<0.5 baseline). This was done separately
for the first 1.5 min (early) or 1.5 to 3.0 min (late) periods post-
exercise. If the global test achieved significance (p < 0.05)
Bonferroni-adjusted pair-wise tests of significance were con-
structed using a Wilcoxon rank-sum test.
Last we developed two models to explore the association
between the three key variables measured in this study: ABI,
StO2, and rBF. The first, a linear model, considers an individual’s
ABI as a function of mean StO2 and percent elevated or depressed
post-exercise rBF as described above for the early or late time
periods. The second, a Cox model, considers the relative rate of
returning to baseline StO2 levels, as a function of ABI and these
same percent elevated or percent depressed rBF variables. For
purposes of brevity, we report only a single two-variable model
for each outcome and exercise, with the rBF variable that achieved
the highest level of significance in our analyses. All statistical
analyses were carried out using either R 2.10 or R 2.15.29
3 Results
3.1 Baseline Characteristics
Table 1 shows baseline characteristics of the subjects. The ABI
from healthy subjects ranged from 0.92 to 1.54, while patients
with mild impairment presented with 0.7 ≤ ABI < 0.9. The ABI
for the moderate/severe patients ranged from 0.33 to 0.7. The
moderate/severe group included 15 subjects whose median
ABI of 0.62 corresponds to 56% of the median ABI in the
healthy group.
While the protocol specified a target length for the duration
of each exercise, the healthy group tended to exercise longer
because subjects with PAD often stopped when they felt
muscle pain. For treadmill, healthy, mild, and moderate/severe
PAD patients exercised for a median of 10.0, 4.0, and 4.2 min,
respectively. For pedal, healthy controls exercised for a median
of 1.9 min compared with a median of 1.4 and 1.5 min for the
mild and moderate/severe PAD groups, respectively. Exercise
times for the two tasks were significantly correlated (ρ ¼ 0.45,
p ¼ 0.0004). For the pedal exercise, no significant differences
in the distribution of work or power was observed among
groups, noting that these variables were missing for five,
two, and one subjects in the healthy, mild PAD and moder-
ate/severe PAD groups, respectively (p ¼ 0.39 for work, p ¼
0.55 for power).
Mean StO2 differed among groups pre-exercise (p ¼ 0.002,
Table 2). The mean (95% CI) StO2 for treadmill was 2.6%
(0.4, 5.6%) higher than for pedal (p ¼ 0.089). Before treadmill,
the mean StO2 of 66.2% for the healthy group was 10.6% (3.5,
17.7%) and 9.3% (2.8, 15.9%) higher than the mild and mod-
erate/severe PAD groups (p ¼ 0.013 and 0.017, respectively).
By contrast, the mild and the moderate/severe PAD patients
differed by only 1%.
3.2 Treadmill Exercise: Individual Trends
in StO2 and rBF
Pre-exercise mean StO2 was strongly associated with post-
exercise StO2 (p < 0.0001). Figure 3 shows the estimated
Table 1 Subject characteristics. Values shown are medians [interquartile range (IQR)], except for race and gender, which show number of subjects
[proportion of subjects for each ankle brachial index (ABI) group].
Baseline characteristics
ABI group
Level
Healthy (n ¼ 31) Mild (n ¼ 11) Moderate/severe (n ¼ 13)
ABI ≥ 0.9 0.9 > ABI ≥ 0.7 0.7 > ABI ≥ 0.3
ABI 1.11 (1.0, 1.2) 0.82 (0.78, 0.85) 0.62 (0.55, 0.66)
Age (years) 64 (59, 70) 69 (57, 71) 69 (68, 78)
Race White 13 (0.42) 5 (0.45) 2 (0.13)
Black 13 (0.42) 5 (0.45) 13 (0.87)
Asian 5 (0.16) 1 (0.09) 0
Gender Male 17 (0.53) 4 (0.36) 7 (0.47)
Female 14 (0.47) 7 (0.64) 8 (0.53)
BMI (kg∕m2) 25.4 (22.7, 31.1) 24.2 (20.9, 30.0) 25.0 (23.5, 29.3)
Exercise time (min) Treadmill 10.0 (10.0, 10.0) 4.0 (2.1, 8.7) 4.2 (3.2, 8.0)
Pedal 1.9 (1.7, 2.1) 1.4 (1.2, 1.8) 1.5 (1.3, 1.9)
Work (J) Pedal 600 (255, 900) 570 (200, 720) 418 (237, 518)
Power (W ) Pedal 289 (153, 458) 382 (169, 509) 256 (153, 458)
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mean hemodynamic responses for each group. Strong evidence
was found for an increase in StO2 over time (p < 0.0001), but
rates of increase did not differ significantly between groups.
Table 2 shows the estimated means at discrete time points,
based on the fit of our model immediately following the
treadmill exercise. Immediately post-exercise, mean StO2 was
depressed to 56.9% (53.2, 60.6%) in the healthy group.
Mean StO2 in the healthy controls exceeded by 11.7% (6.9,
16.5%, p < 0.0001) that of the mild PAD patients,
and 16.6% (12.3, 20.9%, p < 0.0001) that of the moderate/
severe PAD patients. The difference of 4.9% (−0.4, 10.1%)
between the two PAD groups was not significant. Mean values
in all groups gradually returned to the baseline mean for
that group.
Mean pre-exercise StO2 appears as a dashed line in Fig. 3,
with 95% CI as a dotted line. The post-exercise mean for all
three groups recovered to either their pre-exercise mean or
near it, with the recovery appearing most rapid in healthy con-
trols. Consistent with the patterns in Fig. 3, Table 3 shows that
the median time for an individual to return to his/her pre-exer-
cise level, as determined from the Kaplan-Meier method, ranged
from 0.72 min for the healthy subjects to 1.68 min for the mod-
erate/severe PAD patients. While the trend was consistent with
that seen for the mean models (Fig. 3), differences in the rate
of returning to baseline StO2 levels for the PAD and healthy
subjects did not achieve statistical significance.
In contrast to StO2, rBF differed among ABI groups post-
exercise (p ¼ 0.0036), but temporal changes in blood flow
during the 3-min post-exercise observation window were not
detected. Healthy subjects and mild PAD patients showed pro-
nounced elevation in rBF post-exercise with means (95% CI) of
1.45 (1.14, 1.84) and 1.78 (1.22, 2.60), respectively, while mean
rBF in the moderate/severe PAD group of 0.80 (0.51, 1.11) did
not differ from pre-exercise levels. Pairwise comparisons
indicated that mean rBF in the moderate/severe PAD patients
differed from healthy controls (p ¼ 0.017) and mild PAD
patients (p ¼ 0.008), but that mean rBF did not differ signifi-
cantly between the healthy controls and the mild group.
Table 4 examines the rBF data in terms of the proportion of
the post-exercise period when rBF was reduced to 0.5 of base-
line (percent depressed) or exceeded 1.5 of baseline (percent
elevated). For treadmill, there were pronounced differences, par-
ticularly in percent elevated for both early (p ¼ 0.007) and late
post-exercise periods (p ¼ 0.011). Both healthy and mild PAD
subjects had pronounced elevations in blood flow, with a median
percent elevated of at least 45% during early and late post-
exercise periods; in contrast, the median percent elevated for
the moderate/severe group was 20% in the early post-exercise
period and 7% in the late post-exercise period. Differences
between groups in percent depressed were also significant in
the early post-exercise period (p ¼ 0.010); median percent
depressed for healthy and mild subjects were zero compared
to 5.9% for the moderate/severe group.
3.3 Treadmill Exercise: Associations
Between ABI, StO2, and rBF
Because ABI is widely used in the diagnosis and monitoring of
PAD patients, we first assessed the extent to which characteris-
tics of the post-exercise distribution of rBF added to the predic-
tion of ABI, beyond what could be achieved with StO2 alone.
Table 5 shows that mean StO2 in the treadmill post-exercise
period was strongly correlated with ABI (p ¼ 0.001) but
with not percent-depressed rBF. Other characteristics of the
rBF distribution (e.g., median rBF or percent-elevated rBF)
also showed no association (results not shown). We then
modeled the relative rate of returning to baseline for StO2 as a
function of ABI, and the percent-elevated rBF at the early
post-exercise interval. In this two-variable model, the rate of
return to baseline StO2 was not associated with ABI, and it
was only marginally associated with percent elevated rBF
(p ¼ 0.089). Similar trends occurred for the later, 1.5 to
3.0 min, post-exercise period (not shown).
Table 2 Hemodynamic parameters (95% CI) pre- and post-exercise. The models for post-exercise tissue oxygen saturation (StO2) were adjusted for
the pre-exercise mean for each subject. The values shown here are for a subject with the mean equal to the pre-exercise mean for that group.
Parameter Time Exercise
ABI group
Healthy (n ¼ 31) Mild (n ¼ 11) Moderate/severe (n ¼ 15)
StO2 (%) Pre-exercise Treadmill 66.2 (62.2, 70.1) 55.6 (49.3, 61.9)a 56.8 (51.2, 62.4)a
Pedal 63.5 (59.6, 67.5) 53.0 (46.7, 59.2)a 54.2 (48.6, 59.8)a
Immediately post-exercise Treadmill 56.9 (53.2, 60.6) 45.2 (40.3, 50.0)b 40.3 (36.0, 44.5)b
Pedal 51.8 (47.9, 55.8) 33.9 (29.3, 38.5)b 36.3 (30.9, 41.6)b
Relative blood flow (rBF) Immediately post-exercise Treadmillc 1.45 (1.14, 1.84) 1.78 (1.22, 2.60) 0.80 (0.58, 1.11)da
Pedal 1.08 (0.83, 1.39) 0.75 (0.50, 1.13) 0.83 (0.58, 1.19)
3 min post-exercise Treadmillc 1.45 (1.14, 1.84) 1.78 (1.22, 2.60) 0.80 (0.58, 1.11)da
Pedal 1.36 (1.13, 1.64) 1.11 (0.83, 1.49) 0.81 (0.63, 1.05)e
ap < 0.05 compared to healthy.
bp < 0.0001 compared to healthy.
cTreadmill exercise did not have detectable rBF changes over time.
dp < 0.01 compared to mild.
ep < 0.01 compared to healthy.
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3.4 Pedal Exercise: Individual Trends in StO2 and rBF
Pre-exercise mean StO2 was strongly associated with post-
exercise StO2 for pedal exercise (p < 0.0001). Over time,
StO2 increased significantly (p ¼ 0.0001), but the rate of
increase did not differ among ABI groups. As with treadmill
exercise, a pronounced depression in StO2 was observed,
followed by recovery (Fig. 4 and Table 2). Immediately post-
exercise, mean StO2 was 51.8% (47.9, 55.8%) in the healthy
group. This value was 18.0%, (14.0, 22.2%, p < 0.0001) and
15.6% (10.3, 20.9%, p < 0.0001) higher than for the mild
and moderate/severe PAD groups, respectively. The difference
of 2.4% (−3.4, 8.2%) between mild and moderate/severe PAD
groups was not significant.
0.0 1.0 2.0 3.0
20
30
40
50
60
70
0.0 1.0 2.0 3.0
20
30
40
50
60
70
0.0 1.0 2.0 3.0
20
30
40
50
60
70
0.0 1.0 2.0 3.0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
0.0 1.0 2.0 3.0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
0.0 1.0 2.0 3.0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
S t
O
2 
(%
)
S t
O
2 
(%
)
S t
O
2 
(%
)
rB
F
rB
F
rB
F
Time after treadmill
exercise (min)
Time after treadmill
exercise (min)
Time after treadmill
exercise (min)
Time after treadmill
exercise (min)
Time after treadmill
exercise (min)
Time after treadmill
exercise (min)
Healthy Control Mild PAD Moderate/Severe PAD
Fig. 3 Model-based estimates of mean (95% CI) StO2 (top row) and rBF (bottom row) in healthy, mild, and moderate/severe subjects immediately, 0.5,
1.0, and 3.0 min post-treadmill exercise. For the top row, the dashed line is the pre-exercise mean StO2 for each group, and dotted lines are the 95% CI
(top row, see Table 2 for values) or a value of 1.0 for rBF (bottom row).
Table 3 Median time in minutes (95% CI) to return to pre-exercise mean StO2 along with relative rate (the hazard ratio) for returning to pre-exercise
mean StO2 based on a Cox model; UD is undetermined based on the length of time followed. p-Values are shown for the Cox model comparing each
peripheral artery disease (PAD) groups to healthy.
Group
Treadmill Pedal
Median (95% CI) Relative rate (95% CI) p-value Median (95% CI) Relative rate (95% CI) p-value
Healthy 0.72 (0.37, 1.69) 1.0 NA 1.14 (0.95, 2.37) 1.0 NA
Milda 1.14 (0.95, UD) 0.74 (0.036, 1.54) 0.423 3.32 (2.12, UD) 0.29 (0.12, 0.71) 0.007
Moderate/severea 1.68 (0.71, UD) 0.63 (0.31, 1.27) 0.196 2.67 (0.97, UD) 0.44 (0.21, 0.91) 0.027
aThe PAD groups (mild versus moderate/severe) are not significantly different from each other.
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Mean pre-exercise StO2 appears as a dashed line in Fig. 4,
with 95% CI as a dotted line. The post-exercise mean for
all three groups recovered to either their pre-exercise mean
or near it, with the recovery appearing most rapid in healthy
controls and slower in the two PAD groups. More formally,
Table 3 shows that the median time to return to pre-
exercise mean StO2, as determined from the Kaplan-Meier
method, was longer than for treadmill, ranging from
1.14 min for the healthy subjects to 3.32 min for the mild
PAD patients. The relative risk of returning to baseline was
a factor of 0.29 fold lower for mild patients compared
with healthy subjects (p ¼ 0.0007), and 0.44 fold lower for
moderate/severe patients compared with healthy subjects
(p ¼ 0.027).
Table 4 Median (IQR) for percent of time whenmeasurements of rBF for each subject were depressed (below 0.5 of baseline) or elevated (greater than
1.5 of baseline) either early (first 1.5 min) or late (1.5 to 3.0 min post exercise) post-exercise. p-Values are for the overall test of equality among groups;
symbols indicate Bonferonni-adjusted pair-wise significance.
Group
Treadmill early (first 1.5 min) Treadmill late (1.5 to 3.0 min)
% of time depressed % of time elevated % of time depressed % of time elevated
Healthy 0.0 (0.0, 0.0) 53.4 (20.0, 73.0) 0.0 (0.0, 0.0) 45.0 (14.3, 90.4)
Mild 0.0 (0.0, 0.0) 56.5 (48.1, 84.3) 0.0 (0.0, 3.3) 54.5 (27.6, 81.5)
Moderate/severe 5.9 (0, 29.8)ab 20.0 (6.1, 28.8)cd 0.0 (0.0, 0.0) 7.2 (0.0, 36.3)bc
p-value 0.010 0.007 0.171 0.011
Group
Pedal early (first 1.5 min) Pedal late (1.5 to 3.0 min)
% of time depressed % of time elevated % of time depressed % of time elevated
Healthy 0.0 (0.0, 6.4) 5.3 (0.0, 45.5) 0.0 (0.0, 0.0) 17.5 (1.3, 50.3)
Mild 5.6 (0.0, 36.6) 8.9 (2.7, 26.6) 0.0 (0.0, 12.0) 17.2 (0.0, 78.0)
Moderate/Severe 13.8 (3.1, 27.4)c 6.1 (0.0, 17.6) 10.7 (0.0, 20.6)e 7.1 (0.0, 28.8)
p-value 0.025 0.808 0.017 0.433
ap < 0.10 compared to healthy.
bp < 0.05 compared to mild.
cp < 0.05 compared to healthy.
dp < 0.01 compared to mild.
ep < 0.01 compared to healthy.
Table 5 Joint modeling of ABI and rate of StO2 return to baseline.
Type of model Outcome in model Model terms Association with outcomeab (95% CI) p-Value
Treadmill exercise
Linear ABI Mean StO2 0.117 (0.061, 0.171) <0.001
rBF: percent depressed −0.016 (−0.043, 0.009) 0.198
Cox StO2 return to baseline ABI 0.90 (0.28, 2.97) 0.87
rBF: percent elevated 1.09 (0.99, 1.20) 0.089
Pedal exercise
Linear ABI StO2 0.072 (0.030, 0.114) 0.001
rBF: percent depressed −0.027 (−0.056, 0.002) 0.071
Cox StO2 return to baseline ABI 1.10 (0.98, 1.25) 0.097
rBF: percent depressed 1.23 (1.01, 1.59) 0.041
aChange in mean ABI for linear model per 10% change in predictor.
bRelative rate of return to baseline StO2 for Cox model per 0.10 unit increase in ABI or 10% increase in percent elevated rBF or 10% decrease in percent
depressed rBF variable; values above 1.0 indicate a more rapid return to baseline.
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In contrast with the treadmill exercise, the mean rBF immedi-
ately post-pedal exercise did not differ significantly from 1.0 in
any group. The healthy group essentially showed no change in
rBF, with a mean of 1.08 (0.83, 1.40); mild and moderate/severe
PAD groups showed slight, albeit nonsignificant depressions
with means of 0.75 (0.49, 1.14) and 0.83 (0.58, 1.19), respec-
tively. There was evidence of increases in post-pedal exercise
mean rBF over time (p ¼ 0.003) and a suggestion of differences
in post-pedal exercise mean rBF patterns among groups over
time, although these differences did not achieve strict statistical
significance (p ¼ 0.078 overall).
Table 4 shows that, for the pedal exercise, differences in the
degree to which subjects displayed elevation or depression in
rBF for either the early or late periods were more subtle than
for treadmill. There were no differences among groups at either
time interval in the percent elevated, with values ranging from
5.3% to 8.9% during the early post-exercise period, and from
7.1% to 17.5% for the later post-exercise period. Differences
between groups in the percent depressed differed both in
the early (p ¼ 0.025) and the late (p ¼ 0.017) time period.
Notably, the moderate/severe group had median rates of
percent depressed of 13.8% in the early post-exercise phase
and 10.7% in the late post-exercise phase, in contrast with
median rates of 0% for the healthy group.
3.5 Pedal Exercise: Associations Between in ABI,
StO2, and rBF
Table 5 shows that, as with the treadmill exercise, mean StO2 in
the pedal post-exercise period was strongly correlated with
ABI (p ¼ 0.001), but only marginally associated with rBF
(p ¼ 0.071). Other characteristics of the rBF distribution
(e.g., median rBF or percent elevated rBF) showed no associa-
tion with ABI (results not shown). In contrast with the treadmill
exercise, the relative rate of return to baseline StO2 as the out-
come was marginally associated with ABI (p ¼ 0.097), with a
0.10 increase in ABI predicting a 1.10 fold increase in the rate of
return to baseline. In the same model, a 10% decrease in percent-
depressed rBF was associated with a 1.23 fold increase in the
rate of returning to baseline (p ¼ 0.041). Similar trends were
found for the later, 1.5 to 3.0 min, post-exercise period
(not shown).
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4 Discussion
This study employed diffuse optical methodologies to measure
tissue hemodynamics before and after exercise in healthy subjects
and patients with PAD. The optical techniques enable measure-
ments of StO2 and rBF at the microvasculature level in the
extremities. Previously, NIRS alone has been used to evaluate
PAD by measurement of StO2,
30–32 but the present study is the
first report of optical blood flow measurements in a PAD cohort
as well as the first report of all-optical measurements combining
perfusion and tissue oxygenation in an exercising PAD cohort.
Our results showed that baseline StO2 levels between healthy
and PAD groups were significantly different, consistent with
previous reports.31,32 The healthy group had significantly higher
mean StO2 levels (64% to 66%), when compared with the PAD
groups (53% to 57%). The lower oxygen saturation level likely
reflects narrowing of vessels due to the disease and resulting
tissue ischemia. NIRS clearly captures these physiological
differences between the healthy and PAD groups. Within the
PAD groups, however, StO2 levels were similar prior to exercise.
The levels of StO2 immediately post-exercise were reduced
but remained highest in the healthy group, and significantly
lower in both PAD groups, independent of exercise type. The
results showing reduced StO2 levels post-exercise in patients
with PAD were consistent with observations in graded treadmill
tests.31,32 The StO2 recovery to pre-exercise or near pre-exercise
levels occurred in all groups. The relative rate of returning
to baseline StO2 across groups was compared using a Cox
model. Levels consistently rebounded most rapidly to pre-
exercise levels in the healthy group with these trends achieving
significance for the pedal exercise. These findings are also con-
sistent with other NIRS studies in PAD patients.32,33
Measurements of rBF revealed differences in post-exercise
dynamics for healthy and moderate/severe PAD groups. Over
the range of 3 min post-exercise, mean rBF in the healthy group
showed evidence of an increase, relative to baseline, at one or
more post-exercise time points in both types of exercise. In con-
trast, for both the pedal and the treadmill exercises, it was impres-
sive that rBF was severely blunted in the moderate/severe group.
These results were most evident when considering the mean val-
ues, and the proportion of time that individuals spent with either
elevated or depressed levels of rBF. For the treadmill exercise, it
was most notable that moderate/severe PAD patients displayed no
elevation in rBF in contrast to healthy and mild PAD patients. For
the pedal exercise, it was most notable that the moderate/severe
group was more likely to have depressed rBF. Compared with
healthy controls, depressed rBF in the moderate/severe group
is consistent with a severe deficit in the ability of these patients
to respond to the metabolic demands of exercise.
Last, for pedal exercise, an association was demonstrated
between the rate of return to baseline in StO2 and depression in
rBF. Reduced time with depressed rBF in the first 1.5 min post-
exercise was associated with improved rates of return to baseline
StO2. This association was present after adjustment for ABI level,
suggesting that rBF as measured through our DCS system adds
information to our understanding of oxygenation rates in the PAD
patients. This suggests that rBF measurements reflect important
elements of PAD physiology that may be useful in monitoring
PAD in future studies. A similar pattern was observed for tread-
mill, although in this case the association occurred with elevated
rBF, and did not achieve strict statistical significance.
The measured rBF changes from baseline ranged from −50%
to 250%. One might be tempted to compare these observations
with those by ultrasound measurements of blood flow reserve
(i.e., ultrasound measurements which compare flow during-
exercise to flow at rest) of approximately 5 to 10 (Ref. 34),
for example; the observed changes in our study appear generally
lower. However, the blood flow reserve measured with ultra-
sound was calculated during exercise, while here we report
rBF values measured at time-points 30 s and longer post-
exercise. Within this post-exercise time window, the lower
values we observe are quite consistent with an expected rapid
decay in blood flow (e.g., with time constant of ∼10 s) after
cessation of exercise.35,36 Thus the optical flow measurements
are not in disagreement with previous ultrasound flow reserve
observations.
While differences between healthy and moderate/severe PAD
groups were evident in most cases, the mild group demonstrated
intermediate behavior, showing similarities to healthy controls
for treadmill, and similarities to the moderate/severe group for
pedal. The relatively poor precision of the estimates for the mild
group, as evidenced by wide confidence intervals, may reflect
heterogeneity in the functionality of an intermediate group, with
some patients behaving like healthy controls and others appear-
ing more like serious PAD patients. Additionally, since the two
PAD groups had fewer subjects than the control group, the pre-
cision of the estimates for the mean rBF value was reduced. The
data reported here provide important information for guiding the
design of further studies. This includes estimates of the precision
of between-subject estimates of mean StO2 and rBF, the rates
of return to baseline for StO2 and the rates of elevated and
depressed rBF values.
Since the present investigation is primarily a feasibility study,
it employed the standard semi-infinite homogeneous medium
approximation for analysis of the optical data,9 thus ignoring
different tissue layers within muscle. In particular, differences
in adipose tissue thickness may introduce inaccuracies that
might also account for some of the variability within each
group.37 We did not, however, find that the effect of body
mass index (BMI), age and gender (all of which are related
to adipose tissue thickness) altered the associations and results
between ABI groups for either StO2 or rBF.
Claudication often limited completion of exercise protocols
in the mild and moderate/severe groups, particularly during the
pedal exercise. For the analysis of mean StO2 and rBF post-
exercise, we carried out sensitivity analyses to determine how
our results might have been affected by exercise, work, age,
BMI, and gender. No covariate achieved strict statistical signifi-
cance, and our main conclusions were not altered by including
these covariates. Nevertheless we acknowledge that we may
have been underpowered to detect effects of these covariates.
In particular the healthy group exercised longer than the PAD
group so that the effects of longer exercise cannot be completely
disentangled from PAD diagnosis in this study. Future studies
should be designed to more carefully ensure that exercise regi-
mens are consistent across subjects.
The present study protocol did not include measurement
of diffuse optical parameters during exercise due to possible
artifacts generated from muscle movement. Further advance-
ment in technology may allow for flow measurements during
exercise, which could have significant diagnostic value. For
example, demonstrated improvements in DCS data acquisition
speed38,39 and in measurement gating during data acquisition at
specific time points when muscle motion is minimal27 are two
methodologies that could be employed for quasi-continuous
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measurements during exercise. Speedier acquisition can be
achieved with use of a faster acquisition correlator board and
averaging of signals from multiple detectors at the same posi-
tion. In addition, future studies could also obtain absolute blood
flow values by employing venous occlusion calibration of DCS
measurements.27 The present study represents a first step toward
this long-range goal by measuring the effects of two types of
exercise with DCS flow measurements, albeit pre- and post-
exercise.
In summary, this study demonstrated the capability of diffuse
optics to discriminate between moderate/severe PAD patients
and healthy controls and demonstrated an association between
rBF and StO2 levels following pedal exercise in subjects with
large variation in ABI. The combined information obtained
from DCS/NIRS may ultimately assist with diagnosis, progno-
sis, and optimization of treatment in patients with PAD. One
potential application of the instrument is to evaluate inter-
ventions to treat PAD; the present study suggests that an
intervention resulting in shortened time-to-return-to-baseline
StO2 along with an increase in rBF are desirable for PAD
patients. Furthermore, while the present study focuses on mean
differences in response among groups, it may be possible in the
future to monitor individual responses to therapy, providing
personalized assessment of tailored therapies for this debili-
tating condition.
Appendix: Statistical Models for StO2
For the baseline StO2 data, we fit a single mixed effects model to
the combined treadmill and pedal data and compared means
between ABI groups and between exercises. The assessment
of change over time is more complex as the ABI groups poten-
tially change in different ways. Here a separate model was fit for
each exercise. The first step selected one of three models: Model
1 allowed differences among groups but no change over time;
Model 2 allowed differences in ABI groups immediately post-
exercise but then fit a common change over time; Model 3
allowed differences over time that varied among ABI groups.
Nonlinear changes over time were incorporated using a regres-
sion spline; we explored different degrees of freedom, allowing
different levels of curvature in the changes over time. Based on
information criteria, we used a model with 2 deg of freedom for
the StO2 data and a linear model for the rBF data. A random
error term was allowed to vary among ABI groups, and an
autoregressive (AR1) correlation structure allowed the corre-
lation among repeated measurements to decay over time.
Likelihood ratio tests were used to choose a model and to deter-
mine the global significance of differences among ABI groups.
Significance was defined as a p-value less than 0.05 and mar-
ginal significance of between 0.05 and 0.10 was noted.
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